These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 10702547)
1. Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998). Gales AC; Jones RN; Gordon KA; Sader HS; Wilke WW; Beach ML; Pfaller MA; Doern GV J Antimicrob Chemother; 2000 Mar; 45(3):295-303. PubMed ID: 10702547 [TBL] [Abstract][Full Text] [Related]
2. Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000). Gales AC; Sader HS; Jones RN; Diagn Microbiol Infect Dis; 2002 Nov; 44(3):289-99. PubMed ID: 12493177 [TBL] [Abstract][Full Text] [Related]
3. Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different! Jones RN; Beach ML; Pfaller MA Diagn Microbiol Infect Dis; 2001 Nov; 41(3):161-3. PubMed ID: 11750171 [TBL] [Abstract][Full Text] [Related]
4. Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000). Gordon KA; Jones RN; Diagn Microbiol Infect Dis; 2003 Apr; 45(4):295-301. PubMed ID: 12730002 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group. Sader HS; Jones RN; Gales AC; Winokur P; Kugler KC; Pfaller MA; Doern GV Diagn Microbiol Infect Dis; 1998 Dec; 32(4):289-301. PubMed ID: 9934546 [TBL] [Abstract][Full Text] [Related]
6. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Jones RN; Sader HS; Fritsche TR; Pottumarthy S Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923 [TBL] [Abstract][Full Text] [Related]
7. Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997. Jones RN; Kugler KC; Pfaller MA; Winokur PL Diagn Microbiol Infect Dis; 1999 Sep; 35(1):55-63. PubMed ID: 10529882 [TBL] [Abstract][Full Text] [Related]
8. Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000). Kirby JT; Mutnick AH; Jones RN; Biedenbach DJ; Pfaller MA Diagn Microbiol Infect Dis; 2002 Aug; 43(4):303-9. PubMed ID: 12151191 [TBL] [Abstract][Full Text] [Related]
10. Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998-1999. Turnidge J; Bell J; Biedenbach DJ; Jones RN Int J Antimicrob Agents; 2002 Jul; 20(1):10-7. PubMed ID: 12127706 [TBL] [Abstract][Full Text] [Related]
11. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000). Jones RN; Kirby JT; Beach ML; Biedenbach DJ; Pfaller MA Diagn Microbiol Infect Dis; 2002 Jul; 43(3):239-43. PubMed ID: 12106958 [TBL] [Abstract][Full Text] [Related]
12. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Biedenbach DJ; Toleman M; Walsh TR; Jones RN Diagn Microbiol Infect Dis; 2006 Jan; 54(1):13-21. PubMed ID: 16290025 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015. Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952 [TBL] [Abstract][Full Text] [Related]
14. Frequency of occurrence and antimicrobial susceptibility patterns for pathogens isolated from latin american patients with a diagnosis of pneumonia: results from the SENTRY antimicrobial surveillance program (1998). Lewis MT; Gales AC; Sader HS; Pfaller MA; Jones RN Diagn Microbiol Infect Dis; 2000 May; 37(1):63-74. PubMed ID: 10794943 [TBL] [Abstract][Full Text] [Related]
15. Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America). Doern GV; Jones RN; Pfaller MA; Kugler KC; Beach ML Diagn Microbiol Infect Dis; 1999 May; 34(1):65-72. PubMed ID: 10342110 [TBL] [Abstract][Full Text] [Related]
16. Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000). Gales AC; Sader H HS; Jones RN Diagn Microbiol Infect Dis; 2002 Nov; 44(3):301-11. PubMed ID: 12493178 [TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I--results from the SENTRY Antimicrobial Surveillance Program (North America, 1998). Mathai D; Lewis MT; Kugler KC; Pfaller MA; Jones RN; Diagn Microbiol Infect Dis; 2001 Feb; 39(2):105-16. PubMed ID: 11248523 [TBL] [Abstract][Full Text] [Related]
18. Sustained activity and spectrum of selected extended-spectrum beta-lactams (carbapenems and cefepime) against Enterobacter spp. and ESBL-producing Klebsiella spp.: report from the SENTRY antimicrobial surveillance program (USA, 1997-2000). Jones RN; Biedenbach DJ; Gales AC Int J Antimicrob Agents; 2003 Jan; 21(1):1-7. PubMed ID: 12507831 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Mathai D; Jones RN; Pfaller MA; Diagn Microbiol Infect Dis; 2001 Jul; 40(3):129-36. PubMed ID: 11502382 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of bacteria causing urinary tract infections in Latin American hospitals: results from the SENTRY Antimicrobial Surveillance Program (1997). Sader HS; Jones RN; Winokur PL; Pfaller MA; Doern GV; Barrett T; Clin Microbiol Infect; 1999 Aug; 5(8):478-487. PubMed ID: 11856291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]